The effect of continuous positive airway pressure on stair-climbing performance in severe COPD patients

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 2, 2013, Pages 193-199

  Walterspacher, Stephan ^a   Walker, David J ^a   Kabitz, Hans Joachim ^a   Windisch, Wolfram ^b   Dreher, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Lungenklinik Merheim ^*  (Germany)

Author keywords

Dyspnea; Exercise; Mechanical ventilation; Oxygenation; Stair climbing

Indexed keywords

LACTIC ACID;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLIMBING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEOXYGENATION; DISEASE SEVERITY; DYSPNEA; FEASIBILITY STUDY; FEMALE; FLOW RATE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; HYPOVENTILATION; LACTATE BLOOD LEVEL; MALE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84875841377     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.734872     Document Type: Article

References (32)

1. O'Donnell DE. Ventilatory limitations in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2001; 33(7 Suppl):S647-655.
2. Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 2009; 18:66-79.
3. Polkey MI. Muscle metabolism and exercise tolerance in COPD. Chest 2002; 121(5 Suppl):131S-135S.
4. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180(6):506-512.
5. Dreher M, Walterspacher S, Sonntag F, et al. Exercise in severe COPD: is walking different from stair-climbing? Respir Med 2008; 102(6):912-918.
6. Soares SMTP, Oliveira RARA, Franca SA, et al. Continuous positive airway pressure increases inspiratory capacity of COPD patients. Respirology 2008; 13(3):387-393.
7. Lopes AJ, Nery FP, Sousa FC, et al. CPAP decreases lung hyperinflation in patients with stable COPD. Respir Care 2011; 56(8):1164-1169.
8. O'Donnell DE, Sanii R, Younes M. Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure. Am Rev Respir Dis 1988; 138(6):1510-1514.
9. Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory eff ort and dyspnea during exercise in severe COPD. J Appl Physiol 1990; 69(1):179-188.
10. Keilty SE, Ponte J, Fleming TA, et al. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax 1994; 49(10):990-994.
11. Dreher M, Storre JH, Windisch W. Non-invasive ventilation during walking in patients with severe COPD: A randomized cross-over trial. Eur Respir J 2007; 5(29):930-936.
12. Dreher M, Doncheva E, Schwoerer A, et al. Preserving oxygenation during walking in severe chronic obstructive pulmonary disease: noninvasive ventilation versus oxygen therapy. Respiration 2009; 78(2):154-160.
13. World Medical Association. Declaration of Helsinki (Internet). 2008 (cited 14.02.2012); Available from: http://www.wma.net/ en/30publications/ 10policies/b3/ index.html.
14. WHO/NIH. GOLD -The Global Initiative for Chronic Obstructive Lung Disease (Internet). 2011 (cited 14.02.2012); Available from: http://www.goldcopd.org/.
15. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176(6):532-555.
16. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3):511-522.
17. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338.
18. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166(4):518-624.
19. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14(5):377-381.
20. Saghaei M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol 2004; 4(26):1-6.
21. Probst VS, Troosters T, Coosemans I, et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest 2004; 126(4):1102-1107.
22. Sharp JT, Drutz WS, Moisan T, et al. Postural relief of dyspnea in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1980; 122(2):201-211.
23. Grazzini M, Stendardi L, Gigliotti F, et al. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD). Respir Med 2005; 99(11):1403-1412.
24. Stendardi L, Binazzi B, Scano G. Exercise dyspnea in patients with COPD. Int J Chron Obstruct Pulmon Dis 2007; 2(4):429-439.
25. Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(6):1395-1399.
26. O'Donnell DE, Sanii R, Giesbrecht G, et al. Effect of continuous positive airway pressure on respiratory sensation in patients with chronic obstructive pulmonary disease during submaximal exercise. Am Rev Respir Dis 1988; 138(5):1185-1191.
27. O'Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008; 105(2):753-757.
28. O'Donoghue FJ, Catcheside PG, Jordan AS, et al. Effect of CPAP on intrinsic PEEP, inspiratory eff ort, and lung volume in severe stable COPD. Thorax 2002; 57(6):533-539.
29. Romer LM, Polkey MI. Exercise-induced respiratory muscle fatigue: implications for performance. J Appl Physiol 2008; 104(3):879-888.
30. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353(9170):2100-2105.
31. Farre R, Hernandez L, Montserrat JM, et al. Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea. Lancet 1999; 353(9159):1154.
32. Matthys H, Zaiss A, Theissen J, et al. Definitionen, Sollund Meßwerte zur Diagnose obstruktiver, restriktiver sowie gemischter Ventilationsstörungen für die klinische Lungenfunktionsdiagnostik. Atemw-Lungenkrkh. 1995; 3:21130-21138.